Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Endocrinology|January 26, 2010
Increased EpCAM expression in malignant insulinoma: potential clinical implicationsAndreas Raffel, Claus F Eisenberger, Kenko Cupisti, et al.
Oncology Letters|December 2, 2015
Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancerLeila Sisic, Daniel Vallböhmer, Nikolas H Stoecklein, et al.
Nucleic Acids Research|March 18, 2008
High-resolution array comparative genomic hybridization of single micrometastatic tumor cellsChristine Fuhrmann, Oleg Schmidt-Kittler, Nikolas H Stoecklein, et al.
Plos One|December 24, 2015
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast CancerHelen Schneck, Berthold Gierke, Frauke Uppenkamp, et al.
Oncology Letters|February 23, 2018
Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancerLevent Dizdar, Lisa M Jünemann, Thomas A Werner, et al.
BMC Cancer|March 26, 2013
Snail1 expression in colorectal cancer and its correlation with clinical and pathological parametersFeride Kroepil, Georg Fluegen, Daniel Vallböhmer, et al.
Cancers|July 3, 2019
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine ResistanceFlorian Reinhardt, André Franken, Franziska Meier-Stiegen, et al.
International Journal of Cancer|November 2, 2019
Spatiotemporally controlled induction of gene expression in vivo allows tracking the fate of tumor cells that traffic through the lymphaticsNicole Grau, Sandra D Scherer, Melanie Rothley, et al.
Oncology Letters|November 8, 2017
Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomasLevent Dizdar, Monika Tomczak, Thomas A Werner, et al.
European Journal of Medical Research|May 16, 2012
The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical stagingMatthias C Schauer, Nikolas H Stoecklein, Joerg Theisen, et al.
Pageof 10